NVAX

Novavax, Inc. NMS · NVAX

$7.88 -0.33 (-4.02%)

Deep pullback · -2.03σ Hot zone Grade C

+ Compare Open in Sniper

Valuation

Market cap $1.3B

P/E (ttm) —

Forward P/E -14.5

Beta (5y) 2.43

Shares out 164.4M

Div yield —

Profitability & returns

ROE —

Net margin -14.7%

FCF margin 9.8%

Debt / equity —

Trading information

Last price $7.88

Day range $7.84 – $8.30

52-wk range $7.57 – $11.97

Avg volume 4.9M

RSI (2) 0.5

Trend zone Deep pullback

52-week range · today's price

$7.57$11.97

Company

Sector Healthcare

Industry Biotechnology

Exchange NMS

Next earnings 2026-08-05

Novavax, Inc., a biotechnology company, engages in the discovery, development, and commercialization of vaccines to prevent serious infectious diseases in the United States, Europe, and internationally. The company commercializes Nuvaxovid, a COVID-19 vaccine; and R21 Matrix-M adjuvant malaria vaccine. It has license and collaboration agreements with Sanofi, Pfizer Inc., Takeda Pharmaceutical Company Limited, and Ser…